# Task V23: Storage and product formulation (Formulation of gD2 Nanoemulsion Drug Product)

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2020 · $689,419

## Abstract

The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and feasibility assessments; product optimization; product development and cGMP compliant manufacture for Phase I/II clinical studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA).  These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism and emerging and re-emerging infectious diseases.  This contract also provides for manufacture of vaccines, vaccine components including adjuvants, vaccine delivery systems, other biologics, and challenge material.

## Key facts

- **NIH application ID:** 10265801
- **Project number:** 272201800009I-0-759302000003-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** TIM FOUTS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $689,419
- **Award type:** —
- **Project period:** 2018-05-15 → 2028-05-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10265801

## Citation

> US National Institutes of Health, RePORTER application 10265801, Task V23: Storage and product formulation (Formulation of gD2 Nanoemulsion Drug Product) (272201800009I-0-759302000003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10265801. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*